Press release
Global Uterine Manipulators Market to reach USD 464.70 million at a CAGR of 5.64% by 2032, Evaluates DelveInsight
DelveInsight's "Uterine Manipulators Market Insights, Competitive Landscape and Market Forecast-2032" report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers. The report also covers the major emerging products and key Uterine Manipulators companies actively working in the market.
To know more about why North America is leading the market growth in the Uterine Manipulators market, get a snapshot of the report Uterine Manipulators Market Trends
https://www.delveinsight.com/sample-request/uterine-manipulators-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Uterine Manipulators Overview
Uterine manipulators are surgical instruments used during gynecologic procedures, particularly minimally invasive or laparoscopic surgeries like hysterectomy or myomectomy. They are inserted into the uterus through the cervix to provide better access, mobility, and visualization of the uterus. By allowing the surgeon to move and position the uterus precisely, uterine manipulators help improve surgical accuracy, reduce operative time, and minimize complications. Some models also include features for delineating uterine anatomy, facilitating colpotomy, or aiding in the administration of uterine dyes for diagnostic purposes.
DelveInsight Analysis: The Uterine Manipulators market size was valued at approximately USD 300.38 million in 2024 and is projected to grow at a CAGR of 5.64% from 2025 to 2032, reaching around USD 464.70 million by 2032.
Uterine Manipulators Market Insights
Geographically, North America is projected to dominate the uterine manipulators market in 2024, driven by the increasing prevalence of gynecological disorders and a growing number of uterine and endometrial cancer cases. Market growth is further supported by technological innovations in uterine manipulators and ongoing product development. Moreover, the region's advanced healthcare infrastructure, featuring modern hospitals and specialized cancer treatment centers, facilitates the adoption of cutting-edge surgical tools, establishing North America as the leading market for uterine manipulators.
To read more about the latest highlights related to Uterine Manipulators, get a snapshot of the key highlights entailed in the Uterine Manipulators
https://www.delveinsight.com/report-store/uterine-manipulators-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Recent Developments in the Uterine Manipulators Market Report
• In January 2023, Organon made a strategic investment in Claria Medical to support the development of an investigational medical device designed to improve minimally invasive hysterectomy procedures. This investment underscores Organon's dedication to advancing women's health by fostering innovative technologies that enhance surgical outcomes and shorten patient recovery times. The collaboration will concentrate on developing a device aimed at making hysterectomy procedures safer, more precise, and less invasive.
• Thus, owing to such developments in the market, rapid growth will be observed in the Uterine Manipulators market during the forecast period
Key Players in the Uterine Manipulators Market
Some of the key market players operating in the Uterine Manipulators market include- The Cooper Companies Inc., CONMED Corporation, KARL STORZ, Olympus Corporation, Richard Wolf GmbH, Hologic, Inc., Lumenis Be Ltd., B. Braun Melsungen AG, Medline Industries, LP, EndoMed Systems GmbH, Laborie, Conkin Surgical Instrument Ltd., Peters Surgical, IndoSurgicals Private Limited, Utah Medical Products, Inc., Purple Surgical, Stille AB, Aspen Surgical Products, Inc., Hangzhou Kangji Medical Instrument Co., Ltd., Advin Health Care, and others.
Which MedTech key players in the Uterine Manipulators market are set to emerge as the trendsetter explore @ Key Uterine Manipulators Companies
https://www.delveinsight.com/sample-request/uterine-manipulators-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Analysis on the Uterine Manipulators Market Landscape
The uterine manipulators market is also propelled by continuous product development and innovation from leading companies. Manufacturers are introducing advanced devices featuring improved ergonomics, greater flexibility, and compatibility with minimally invasive and robotic surgeries, enhancing surgical efficiency and patient safety. For instance, CooperSurgical's RUMI® II system improves access during laparoscopic hysterectomies. Such innovations help reduce operating time and enhance outcomes, promoting wider adoption in hospitals and clinics. Furthermore, investments in expanding product portfolios and securing regulatory approvals are strengthening market presence, contributing to overall market growth.
Scope of the Uterine Manipulators Market Report
• Coverage: Global
• Study Period: 2022-2032
• Uterine Manipulators Market Segmentation By Device Type: Instruments and Accessories
• Uterine Manipulators Market Segmentation By Usability: Re-usable and Single Use
• Uterine Manipulators Market Segmentation By Application Channel: Hysterectomy and Myomectomy
• Uterine Manipulators Market Segmentation By End-User: Hospitals, Ambulatory Surgical Centers, and Others
• Uterine Manipulators Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World
• Key Uterine Manipulators Companies: The Cooper Companies Inc., CONMED Corporation, KARL STORZ, Olympus Corporation, Richard Wolf GmbH, Hologic, Inc., Lumenis Be Ltd., B. Braun Melsungen AG, Medline Industries, LP, EndoMed Systems GmbH, Laborie, Conkin Surgical Instrument Ltd., Peters Surgical, IndoSurgicals Private Limited, Utah Medical Products, Inc., Purple Surgical, Stille AB, Aspen Surgical Products, Inc., Hangzhou Kangji Medical Instrument Co., Ltd., Advin Health Care, and others
• Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View
Interested in knowing how the Uterine Manipulators market will grow by 2032? Click to get a snapshot of the Uterine Manipulators Market Analysis
https://www.delveinsight.com/sample-request/uterine-manipulators-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Contact Us
Gaurav Bora
info@delveinsight.com
+14699457679
www.delveinsight.com
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Uterine Manipulators Market to reach USD 464.70 million at a CAGR of 5.64% by 2032, Evaluates DelveInsight here
News-ID: 4216613 • Views: …
More Releases from DelveInsight Business Research
Geographic Atrophy Clinical Trial Analysis: 25+ Drugs, 23+ Companies Redefining …
DelveInsight's newly released report, "Geographic Atrophy Pipeline Insight" offers a comprehensive analysis of the evolving Geographic Atrophy (GA) therapeutic landscape, covering 23+ biopharmaceutical companies and 25 investigational drug candidates. The report features in-depth profiles of both clinical- and preclinical-stage assets, along with a detailed therapeutic assessment categorized by product type, development phase, route of administration, and molecular class. It also provides visibility into inactive and discontinued pipeline programs within the…
Interstitial Lung Disease Clinical Trial Analysis: 120+ Drugs and 120+ Companies …
DelveInsight, a prominent market intelligence and consulting organization in the life sciences domain, has announced the launch of its newest report titled "Interstitial Lung Disease Pipeline Insight, 2025." The publication delivers a comprehensive analysis of the fast-advancing therapeutic environment for Interstitial Lung Disease (ILD). With over 120 biopharmaceutical companies actively developing 120+ pipeline assets, the ILD pipeline is witnessing remarkable growth fueled by strong scientific innovation, clinical progress, and regulatory…
Global Vein Illumination Devices Market Forecast to Reach USD 152.83 Million by …
DelveInsight's latest publication, "Vein Illumination Devices Market Insights, Competitive Landscape and Market Forecast-2032," offers a comprehensive analysis of existing and future market dynamics. The report examines evolving trends, technological advancements, key market challenges, growth catalysts, and limiting factors, while also showcasing upcoming product launches and profiling the major players influencing the vein illumination devices industry.
Based on DelveInsight's most recent evaluation, the global vein illumination devices market is anticipated to experience…
Liver Cancer Clinical Trial Analysis: 75+ Drugs, 70+ Companies Redefining the Fu …
DelveInsight's "Liver Cancer Pipeline Insights 2025" delivers an in-depth overview of the liver cancer pipeline ecosystem, profiling more than 70 companies and 75+ therapeutic candidates under development. The report thoroughly examines liver cancer drug profiles across both clinical and preclinical stages. It also evaluates the therapeutic landscape by product category, development phase, route of administration, and molecular class, while additionally identifying inactive and discontinued assets within the pipeline.
Stay informed with…
More Releases for Uterine
Uterine Fibroids Symptoms
USA Fibroids Center is here to offer detailed information on https://www.usafibroidcenters.com/blog/uterine-fibroids-symptoms/ and help you discuss the best treatments for uterine fibroids at the clinic.
Find out the best Fibroid Treatment for you!
Treatments for uterine fibroids are accessed in women with problems related to them and show symptoms such as heavy menstrual bleeding, pain or pressure in the pelvis, or infertility and sterility.
…
Bharath Hospital Kottayam Offers Minimally Invasive Treatment for Uterine Fibroi …
Bharath Hospital Kottayam is excited introduce the latest advancement in women's healthcare - the Uterine Fibroid Embolization (UFE) treatment. Uterine fibroids are non-cancerous growths that form in the uterus. They are a common condition among women, especially those of reproductive age. These tumors can vary in size, from small growths to large masses that can distort the shape of the uterus. Although many women with uterine fibroids experience no symptoms,…
Uterine Manipulator Devices Market Report 2018: Segmentation by Type (Donnez Typ …
Global Uterine Manipulator Devices market research report provides company profile for ConMed, Richard Wolf, Bisinger, Planmeca Oy, Ethicon Endosurgery, Cooper Surgical, Hospiiniz International, C. R. Bard and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025,…
Uterine Fibroids Treatment Market : Hysterectomy to Remain Most Preferred Uterin …
The market for uterine fibroids treatment market is fragmented in nature with a high number of players operating in it across the U.S., states a new market research report by Transparency Market Research. The estimated entry of new players and the increasing research and development activities are some of the key factors that are projected to strengthen the competitive scenario of the market throughout the forecast period. The leading players…
Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H2 2018 - Research By Ma …
Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H2 2018, provides an overview of the Uterine Leiomyoma (Uterine Fibroids) (Non Malignant Disorders) pipeline landscape.
Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Uterine Leiomyoma (Uterine Fibroids) (Non Malignant Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers…
Uterine Fibroids Treatment Market: Rising Prevalence of Uterine Fibroids amongst …
The high prevalence of uterine fibroids across the U.S. has created a significant demand for uterine fibroid treatments across the countries. The growing public concern about the occurrence of uterine fibroids, which are also called uterine leiomyoma, have propelled the demand for treatments and solutions to alleviate the pain, excessive bleeding, and pelvic discomfort.
According to the report by Transparency Market Research, the U.S. uterine fibroid treatment market is anticipated to…
